Tag: life and health reinsurance market report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Interventional Oncology Devices Market Size And Revenue Outlook Through 2030#_x000D_

The interventional oncology devices market has experienced significant expansion recently. It is projected to grow from $2.5 billion in 2025 to $2.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. Historically, this expansion has been driven by factors such as an increase in cancer incidence rates, the proliferation of interventional radiology practices, enhancements in imaging technologies, a greater adoption of minimally invasive oncology treatments, and the presence of specialized oncology centers._x000D_

_x000D_

The interventional oncology devices market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach a valuation of $3.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the projection period include the escalating demand for specific cancer treatments, increased capital allocation in precision oncology, the proliferation of outpatient facilities for cancer care, the wider embrace of combined interventional treatment approaches, and innovations in ablation and embolization technologies. Key trends anticipated for the forecast timeframe encompass the expanding use of image-guided devices for tumor ablation, the growing preference for less invasive cancer treatment methods, the increasing implementation of embolization treatments, the broader application of precision oncology interventions, and improved integration of sophisticated imaging support systems._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=13934096&type=smp&name=Interventional%20Oncology%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Interventional Oncology Devices Market Growth Catalysts And Demand Drivers#_x000D_

The rising incidence of cancer is anticipated to drive the future expansion of the interventional oncology devices market. Cancer is defined as a collection of diseases marked by the unregulated proliferation and dispersion of unusual cells throughout the body, which can aggregate into masses or tumors. This widespread occurrence of cancer significantly elevates the demand for interventional oncology devices, which are crucial for the diagnosis, treatment, and ongoing management of the disease, facilitating early identification, staging, and monitoring. For example, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that the number of cancer cases diagnosed in Australia climbed from 160,570 in 2022 to 164,694 in 2023, representing a considerable increase over the period. This upward trajectory underscores the escalating prevalence of cancer nationwide. Thus, the high prevalence of cancer is a key factor propelling the growth of the interventional oncology devices market._x000D_

_x000D_

#Interventional Oncology Devices Market Segment Landscape And Growth Outlook#_x000D_

The interventional oncology devices market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Embolization Devices, Ablation Devices, Support Devices_x000D_

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization_x000D_

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types_x000D_

_x000D_

Subsegments:_x000D_

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents_x000D_

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices _x000D_

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems _x000D_

_x000D_

#Interventional Oncology Devices Market Trends Shaping Long-Term Demand#_x000D_

Leading companies within the interventional oncology devices market are concentrating on technologies, such as tissue volume, to enhance the accuracy of diagnoses and the effectiveness of treatment in oncology procedures. Tissue volume refers to the amount of biological tissue collected during a biopsy. Larger tissue volumes enable more comprehensive samples to be obtained, which improves diagnostic precision and the efficacy of treatment planning. As an illustration, in June 2023, Argon Medical, a US-based medical device company, launched the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage is designed to collect up to 35% more samples than leading competitors, thereby reducing the necessity for multiple passes during biopsies. This feature is critical for securing sufficient tissue samples for an accurate diagnosis._x000D_

_x000D_

#Interventional Oncology Devices Market Leading Players And Competitive Positioning#_x000D_

Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation _x000D_

_x000D_

#View The Full Interventional Oncology Devices Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Interventional Oncology Devices Market Regional Split: Which Areas Are Fueling Growth?#_x000D_

North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Interventional Oncology Devices Market Through 2030?

The interventional oncology devices market size has experienced considerable expansion in recent years. It is projected to increase from $2.5 billion in 2025 to $2.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. This growth witnessed in the historic period can be attributed to increasing cancer incidence rates, the expansion of interventional radiology practices, advancements in imaging technologies, the growing adoption of minimally invasive oncology treatments, and the availability of specialized oncology centers.

The interventional oncology devices market is poised for significant growth in the coming years. It is projected to reach $3.5 billion by 2030, at a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period can be attributed to an increasing demand for targeted cancer therapies, rising investments in precision oncology, the expansion of outpatient cancer treatment settings, a growing adoption of combination interventional therapies, and technological advancements in ablation and embolization devices. Key trends emerging in the forecast period include the increasing adoption of image-guided tumor ablation devices, a rising use of minimally invasive cancer treatments, the growing deployment of embolization therapies, an expansion of precision oncology procedures, and enhanced integration of advanced imaging support systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Core Drivers Are Transforming The Interventional Oncology Devices Market?

The increasing occurrence of cancer is projected to drive the expansion of the interventional oncology devices market in the future. Cancer is defined as a collection of illnesses marked by the unregulated proliferation and dissemination of atypical cells within the body. Such atypical cells have the potential to develop into masses or tumors. The widespread incidence of cancer increases the need for interventional oncology devices, given their application in the diagnosis, therapeutic intervention, and ongoing care of cancer, thereby assisting in early identification, disease classification, and continuous observation. For example, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in Australia, cancer diagnoses grew from 160,570 in 2022 to 164,694 in 2023, showing a significant increase during that year. This rising pattern underscores the expanding incidence of cancer within the nation. Consequently, the elevated frequency of cancer is fueling the expansion of the interventional oncology devices market.

What Key Segment Areas Are Included In The Interventional Oncology Devices Market Assessment?

The interventional oncology devices market covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Which Trends Are Influencing The Expansion Of The Interventional Oncology Devices Market?

Key companies operating in the interventional oncology devices market are concentrating on technologies, such as tissue volume, to improve diagnostic precision and treatment effectiveness in oncology procedures. Tissue volume refers to the quantity of biological tissue gathered during a biopsy. Larger tissue volumes can yield more comprehensive samples, thus enhancing the accuracy of diagnoses and the efficiency of treatment planning. For instance, in June 2023, Argon Medical, a US-based medical device company, introduced the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage can collect up to 35% more samples than leading competitors, which minimizes the requirement for multiple passes during biopsies. This attribute is essential for acquiring adequate tissue samples for an accurate diagnosis.

Which Organizations Are Operating Within The Interventional Oncology Devices Market?

Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

Access The Complete Interventional Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Geographic Region Represents The Largest Interventional Oncology Devices Market Share?

North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Interventional Oncology Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2026, By The Business Research Company

Cardiovascular Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Interventional Oncology Devices Market In 2026, And How Will Its Value Evolve By 2030?

The interventional oncology devices market has observed robust expansion in recent years. This market is forecasted to increase from $2.5 billion in 2025 to $2.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market can be linked to several factors including rising cancer incidence rates, the broadening of interventional radiology practices, enhancements in imaging technologies, increasing adoption of minimally invasive oncology treatments, and the establishment of specialized oncology centers.

The interventional oncology devices market is projected to experience substantial expansion in the coming years, reaching a valuation of $3.5 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period can be linked to several factors, including the escalating demand for targeted cancer treatments, increased capital allocation in precision oncology, the proliferation of outpatient facilities for cancer care, a wider uptake of integrated interventional therapies, and innovations in ablation and embolization technologies. Key trends expected during the forecast timeframe encompass the expanding utilization of image-guided devices for tumor ablation, a surge in the application of minimally invasive approaches for cancer treatment, a broader implementation of embolization techniques, the proliferation of precision oncology interventions, and improved incorporation of advanced imaging support systems.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Key Drivers Are Fueling The Growth Of The Interventional Oncology Devices Market?

The increasing occurrence of cancer is projected to drive the expansion of the interventional oncology devices market in the future. Cancer constitutes a range of illnesses defined by the unchecked proliferation and dissemination of atypical cells within the organism. These atypical cells have the capacity to develop into masses or tumors. The widespread presence of cancer escalates the need for interventional oncology devices, given their application in the identification, therapy, and handling of cancer, aiding in timely discovery, classification, and observation. As an illustration, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that within Australia, the count of diagnosed cancer cases climbed from 160,570 in 2022 to 164,694 in 2023, signifying a considerable increase during that year. This rising trajectory underscores the expanding occurrence of cancer across the nation. Consequently, the substantial incidence of cancer is fueling the expansion of the interventional oncology devices market.

How Is The Interventional Oncology Devices Market Broken Down By Segment Categories?

The interventional oncology devices market covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

What Trends Are Influencing The Interventional Oncology Devices Market?

Leading companies in the interventional oncology devices market are concentrating on technologies, including tissue volume, to improve diagnostic precision and treatment effectiveness in oncology procedures. Tissue volume defines the quantity of biological tissue gathered during a biopsy. Bigger tissue volumes can yield more exhaustive samples, thus enhancing the accuracy of diagnoses and the efficacy of treatment strategies. For example, in June 2023, Argon Medical, a US-based medical device company, unveiled the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage can gather up to 35% more samples compared to major competitors, which subsequently lessens the requirement for multiple passes during biopsies. This attribute is vital for acquiring sufficient tissue samples necessary for an accurate diagnosis.

Which Players Are Present In The Interventional Oncology Devices Market Space?

Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

Get The Full Interventional Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Region Represents The Largest Share Of The Interventional Oncology Devices Market?

North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Interventional Oncology Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2026, By The Business Research Company

Cardiovascular Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Interventional Oncology Devices Market Between 2026 And 2030?

The interventional oncology devices market has experienced robust expansion in recent years. Its size is projected to increase from $2.5 billion in 2025 to $2.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. The growth observed historically can be linked to several factors, including rising cancer incidence rates, the expansion of interventional radiology practices, continuous improvements in imaging technologies, the increasing adoption of minimally invasive oncology treatments, and the availability of specialized oncology centers.

The interventional oncology devices market is projected to experience substantial expansion in the coming years. Its size is anticipated to reach $3.5 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This growth over the forecast period is attributable to several factors, including heightened demand for targeted cancer treatments, increased investments in precision oncology, the widening availability of outpatient cancer treatment facilities, the growing acceptance of combination interventional therapies, and breakthroughs in ablation and embolization device technology. Key trends anticipated during this period encompass the greater embrace of image-guided tumor ablation devices, an increase in minimally invasive cancer treatment applications, the expanding use of embolization therapies, a rise in precision oncology procedures, and improved incorporation of advanced imaging support systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Key Drivers Are Influencing The Growth Of The Interventional Oncology Devices Market?

The widespread occurrence of cancer is anticipated to propel the growth of the interventional oncology devices market moving forward. Cancer refers to a group of illnesses characterized by the uncontrolled multiplication and dissemination of abnormal cells within the body. These atypical cells can form masses or tumors. The substantial prevalence of cancer drives up the demand for interventional oncology devices, as these instruments are utilized in the diagnosis, treatment, and management of cancer, assisting with early detection, staging, and monitoring. For instance, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in Australia, the count of diagnosed cancer cases rose from 160,570 in 2022 to 164,694 in 2023, demonstrating a significant increase over the year. This upward trajectory emphasizes the expanding prevalence of cancer within the country. Therefore, the significant prevalence of cancer is a primary driver for the growth of the interventional oncology devices market.

Which Market Segments Are Examined In The Interventional Oncology Devices Market Study?

The interventional oncology devices market covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Which Trends Are Influencing The Interventional Oncology Devices Market?

Leading companies in the interventional oncology devices market are concentrating on technologies like tissue volume to improve diagnostic precision and treatment effectiveness in oncology procedures. Tissue volume denotes the quantity of biological tissue acquired during a biopsy. Greater tissue volumes yield more comprehensive samples, which enhances diagnostic accuracy and optimizes treatment planning. For example, in June 2023, Argon Medical, a US-based medical device firm, unveiled the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage is designed to collect up to 35% more samples than prominent competitors, thereby reducing the requirement for multiple passes during biopsies. This attribute is essential for securing adequate tissue samples necessary for accurate diagnosis.

Who Are The Primary Competitors In The Interventional Oncology Devices Market?

Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

Read the full interventional oncology devices market report here:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Interventional Oncology Devices Market?

North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Interventional Oncology Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2026, By The Business Research Company

Cardiovascular Surgery Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiac Assist Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Interventional Oncology Devices Market from 2026 to 2030?

The interventional oncology devices market has experienced robust growth in recent years. This market is expected to expand from $2.5 billion in 2025 to $2.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. The historical increase in market size can be attributed to increasing cancer incidence rates, the expansion of interventional radiology practices, advancements in imaging technologies, the growing adoption of minimally invasive oncology treatments, and the availability of specialized oncology centers.

The interventional oncology devices market size is anticipated to undergo robust expansion in the near future. It is projected to increase to $3.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period can be primarily attributed to an escalating demand for targeted cancer therapies, growing investments in precision oncology, the broadening of outpatient cancer treatment environments, an increasing embrace of combination interventional therapies, and advancements in ablation and embolization device technology. Significant developments expected within this forecast period involve the rising uptake of image-guided tumor ablation devices, an increase in the use of minimally invasive cancer treatments, the expanding implementation of embolization therapies, the extension of precision oncology procedures, and improved integration of advanced imaging support systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Drivers Are Affecting Demand In The Interventional Oncology Devices Market?

The widespread occurrence of cancer is projected to propel the expansion of the interventional oncology devices market in the coming years. Cancer is defined as a collection of illnesses marked by the unregulated proliferation and dissemination of anomalous cells within the body, which can aggregate to form masses or tumors. This high prevalence of cancer stimulates the demand for interventional oncology devices, given their essential role in the diagnosis, treatment, and management of cancer, thereby aiding in early detection, accurate staging, and continuous monitoring. For example, in July 2024, figures from the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that in Australia, the number of diagnosed cancer cases rose from 160,570 in 2022 to 164,694 in 2023, demonstrating a significant increase during that period. This observed upward trend underscores the increasing prevalence of cancer within the country. Therefore, the significant prevalence of cancer is a key driver for the growth of the interventional oncology devices market.

Which Segment Groups Are Influencing The Interventional Oncology Devices Market?

The interventional oncology devices market covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Which Trends Are Expected To Influence The Interventional Oncology Devices Market In The Upcoming Years?

Major companies operating in the interventional oncology devices market are prioritizing technologies, such as tissue volume, to elevate diagnostic precision and treatment effectiveness in oncology procedures. Tissue volume signifies the quantity of biological tissue acquired during a biopsy process. Obtaining greater tissue volumes can yield more comprehensive samples, consequently boosting the accuracy of diagnoses and the efficacy of treatment planning. For instance, in June 2023, Argon Medical, a US-based medical device company, unveiled the SuperCore Advantage semi-automatic biopsy. The SuperCore Advantage is capable of collecting up to 35% more samples than its main competitors, which in turn diminishes the requirement for multiple passes during biopsies. This characteristic is vital for securing sufficient tissue samples needed for accurate diagnosis.

Who Are The Primary Competitors In The Global Interventional Oncology Devices Market?

Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Regions Are Projected To Dominate The Interventional Oncology Devices Market In The Coming Years?

North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Interventional Oncology Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2026, By The Business Research Company

Cardiovascular Surgery Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiovascular Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the interventional oncology devices market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Interventional Oncology Devices Market Size?

The interventional oncology devices market has experienced consistent growth in recent years. This market is expected to expand from $2.39 billion in 2024 to $2.5 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. Historically, the expansion can be attributed to factors such as an aging population, a rise in cancer cases, increased spending on pharmaceutical research and development, higher healthcare expenditure, and an increasing number of healthcare facilities.

The interventional oncology devices market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $3.28 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.0%. During the forecast period, this growth is primarily driven by factors such as an aging demographic, a rising inclination towards minimally invasive surgeries (MIS), greater investment in research and development, an uptick in healthcare spending, significant opportunities in developing economies, and the growing incidence of cancer and other chronic conditions. Key trends expected in this timeframe involve a strong emphasis on creating advanced image-guided oncology devices, leveraging AI for innovative device creation, introducing novel and effective embolic devices to enhance oncology procedures, integrating robotics technology, and fostering collaborations with other firms and research institutions to expedite product innovation and development.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Core Market Drivers Are Expanding The Interventional Oncology Devices Industry?

Leading companies in the interventional oncology devices market are concentrating on technologies, including tissue volume, to elevate diagnostic precision and treatment success in oncology procedures. Tissue volume denotes the quantity of biological tissue harvested during a biopsy. Increased tissue volumes yield more comprehensive samples, which subsequently enhances diagnostic accuracy and refines treatment planning. For example, in June 2023, Argon Medical, a US-based medical device company, introduced the SuperCore Advantage semi-automatic biopsy. This device can obtain up to 35% more samples than prominent competitors, thereby reducing the requirement for multiple passes during biopsies. Such a feature is crucial for securing adequate tissue samples vital for an accurate diagnosis.

What Segment Insights Are Highlighted In The Interventional Oncology Devices Market Report?

The interventional oncology devicesmarket covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Which Notable Trends Are Transforming The Interventional Oncology Devices Market Outlook?

Leading corporations are concentrating on the implementation of robotics technology in interventional oncology devices to achieve enhanced efficiency. This robotic system seamlessly combines image-based planning and navigation with the precise insertion of various instruments into the intended body part, resulting in improved accuracy and effectiveness. An example of this is the U.S. Food and Drug Administration’s approval of Quantum Surgical’s Epione interventional oncology robotics platform in March 2022.

Which Firms Are Driving Innovation Within The Interventional Oncology Devices Market?

Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

What Regional Trends Are Shaping Growth In The Interventional Oncology Devices Market?

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2025, By The Business Research Company

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

3D Medical Imaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Interventional Oncology Devices Market Expected To Become By 2029 Compared With Its 2025 Level?

The market for interventional oncology devices has demonstrated consistent upward momentum through recent years, projected to expand from a value of $2.39 billion in 2024 to $2.5 billion the following year, reflecting a compound annual growth rate (CAGR) of 4.4%. This upward trajectory observed during the historical period is linked to several key factors, including a burgeoning elderly demographic, a rise in cancer incidence across populations, greater investment in pharmaceutical research and development, escalating overall healthcare spending, and an augmentation in the availability of medical care establishments.

Anticipation surrounds the interventional oncology devices sector, projecting a robust expansion in the upcoming years, with market valuation projected to reach an impressive $3.28 billion by 2029, underpinned by a compound annual growth rate (CAGR) of 7.0%; this upward trajectory is fueled by several key factors, including the expanding demographic of elderly individuals, a growing inclination toward minimally invasive surgical techniques, escalated investment in research and development initiatives, a general upward trend in healthcare spending, untapped opportunities within developing nations, and the rising incidence rates associated with cancer and various chronic illnesses; meanwhile, dominant trends shaping this market landscape involve a concentrated effort toward engineering sophisticated, image-guided oncology apparatus, the integration of artificial intelligence for pioneering device creation, the introduction of novel embolic agents designed to enhance oncological interventions, an increased emphasis on leveraging robotic technologies, and strategic alliances formed with other enterprises and academic bodies to fast-track both product enhancement and groundbreaking discoveries.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

Which Major Market Drivers Are Shaping The Future Of The Interventional Oncology Devices Market?

A central strategy for key players within the interventional oncology device sector is concentrating efforts on advancements like tissue volume measurement to elevate both the precision of diagnostic assessments and the overall success rate of oncological interventions. Tissue volume is defined by the quantity of biological material secured throughout the biopsy process; securing greater tissue amounts generally leads to more thorough sample data, thereby boosting diagnostic reliability and refining the suitability of treatment strategies. Illustratively, in June of 2023, Argon Medical, a medical device firm situated in the United States, introduced its SuperCore Advantage semi-automatic biopsy system, a device capable of gathering samples that surpass those of primary rivals by as much as 35 percent, consequently minimizing the necessity for repeated puncture attempts during the biopsy, a capability vital for ensuring sufficient tissue acquisition essential for a precise diagnosis.

How Is The Interventional Oncology Devices Market Segmented?

The interventional oncology devicesmarket covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Which Key Trends Are Expected To Influence The Interventional Oncology Devices Market In The Coming Years?

A key trend among leading corporations involves the incorporation of robotics into interventional oncology instruments, aiming to achieve superior operational effectiveness. This robotic framework successfully merges pre-procedure imaging guidance and navigation capabilities with the precise placement of various tools into the targeted anatomical region, thereby enhancing both accuracy and throughput. A concrete illustration of this progress is the U.S. Food and Drug Administration’s endorsement in March 2022 of Quantum Surgical’s Epione interventional oncology robotics system.

Who Are The Key Multinational Companies Dominating The Interventional Oncology Devices Market?

Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Interventional Oncology Devices Market?

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Interventional Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Devices Market 2025, By The Business Research Company

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

3D Medical Imaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Interventional Oncology Devices Market Expected to Grow Between 2025 And 2029?

In recent times, there has been consistent growth in the market size of interventional oncology devices. It’s projected to expand from $2.39 billion in 2024 to $2.5 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. Various factors contribute to this historical growth, including an aging populace, rising cancer cases, increased spending on pharmaceutical research and development, higher healthcare expenditure, and an increase in the number of health care facilities.

The market for interventional oncology devices is predicted to experience robust growth in the upcoming years, with projections to reach $3.28 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.0%. The market expansion during the prediction period can be ascribed to the growing elderly population, amplified preference for minimally invasive surgeries (MIS), escalated R&D expenditure, increased healthcare spending, high potential in budding economies and a surge in cancer and chronic disease cases. Anticipated trends for this period involve focusing on the creation of advanced image-guided oncology devices, employing AI for innovative device creation, developing novel, advanced embolic devices for enhanced oncology procedures, the use of robotics technology, and cooperation with other corporations and research bodies to expedite product development and innovation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

Which Factors and External Forces Are Driving Demand in the Interventional Oncology Devices Market?

Valuable players in the field of interventional oncology devices are concentrating on technologies like tissue volume, aiming at amplifying the precision of diagnoses and the efficacy of oncology treatments. Tissue volume denotation is the quantity of biological tissue retrieved during the biopsy proceedings. Higher volumes of tissue can afford more extensive samples, thereby amplifying the correctness of the diagnosis and the efficiency of the treatment strategy. For instance, Argon Medical, a medical device firm headquartered in the US, introduced the SuperCore Advantage semi-automatic biopsy in June 2023. The SuperCore Advantage is competent in securing up to 35% more samples compared to its primary competitors, cutting down the requirement for multiple passes during biopsies. This functionality plays a pivotal role in acquiring ample tissue samples for precise diagnosis.

Which Segments in the Interventional Oncology Devices Offer the Most Growth?

The interventional oncology devicesmarket covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Interventional Oncology Devices Market?# Market?

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theInterventional Oncology Devices Market’s Growth?

Prominent businesses are prioritizing the implementation of robotics technology in interventional oncology devices to increase efficiency. The robotic system combines image-guided planning and navigation with the placement of varying instruments onto the precise body part with enhanced accuracy and efficiency. For example, in March 2022, Quantum Surgical’s Epione interventional oncology robotics platform received approval from the U.S. Food and Drug Administration.

View the full report here:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

What Are the Key Elements That Define the Interventional Oncology Devices Market?

Interventional oncology devices refer to medical tools and technologies used to diagnose and treat cancer through minimally invasive procedures. They are used to target tumors directly, delivering treatments like ablation or embolization while minimizing damage to surrounding healthy tissue.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3304

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Interventional Oncology Devices Market Size Changed, over the years?

There has been significant growth in the market size of interventional oncology devices in recent years. The market is projected to expand from $2.39 billion in 2024 to $2.52 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historic period include an ageing demographic, a rise in cancer cases, an uptick in R&D spending in the pharmaceutical sector, higher healthcare expenses, and an increase in the number of healthcare facilities.

How Much Will the Interventional Oncology Devices Market Be Worth in 2029?

In the coming years, substantial growth is expected in the interventional oncology devices market which is poised to reach $3.34 billion by 2029 with a compounded annual growth rate of 7.3%. Factors predicted to contribute to growth during this forecast period include a rising aged population, heightened preference for minimally invasive procedures, increased spending on research and development, higher healthcare expenses, significant potential in upcoming economies and a surge in cancer and chronic illness cases. Looking towards the future, key trends will focus on the creation of advanced, image-guided oncology devices, leveraging artificial intelligence for innovative development, and introducing new and inventive embolic devices for enhanced oncology treatments. Thriving on technological advancements, the impact of robotics in this market segment is significant, as is the importance of corporate collaboration and research institution alliances to fast-track the development and innovation of products.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

Which is the Largest Company in the Interventional Oncology Devices Market?

Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

What Are the Main Market Drivers in the Interventional Oncology Devices Industry?

Key players in the interventional oncology devices market, like Argon Medical, are placing a significant emphasis on technological advancements such as tissue volume to boost diagnostic precision and the efficiency of treatment in oncology procedures. The term tissue volume refers to the quantity of biological tissue gathered during the biopsy process. Securing larger tissue volumes can offer more detailed samples which in turn enhances diagnosis accuracy and treatment planning effectiveness. An illustration of this is when Argon Medical, a medical device enterprise based in the US, introduced the SuperCore Advantage semi-automatic biopsy in June 2023. The SuperCore Advantage has the ability to gather up to 35% more samples compared to top competitors, reducing the necessity for extra passes in biopsies. This characteristic is vital for securing sufficient tissue samples to ensure a precise diagnosis.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

How Is the Interventional Oncology Devices Market Segments Structured?

The interventional oncology devices market covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

What Strategic Trends Are Transforming the Interventional Oncology Devices Market?

Top corporations are concentrating their efforts on the incorporation of robotics technology in interventional oncology devices to achieve greater effectiveness. The robotic mechanism enhances image-guided planning and navigation, allowing for more precise and efficient positioning of various tools on the intended body part. As an example, Quantum Surgical’s Epione interventional oncology robotics platform received approval from the U.S. Food and Drug Administration in March 2022.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Which Global Regions Offer the Highest Growth in the Interventional Oncology Devices Market?

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3304

This Report Delivers Insight On:

1. How big is the interventional oncology devices market, and how is it changing globally?

2. Who are the major companies in the interventional oncology devices market, and how are they performing?

3. What are the key opportunities and risks in the interventional oncology devices market right now?

4. Which products or customer segments are growing the most in the interventional oncology devices market?

5. What factors are helping or slowing down the growth of the interventional oncology devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the interventional oncology devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Interventional Oncology Devices Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for interventional oncology devices has seen a robust enhancement in recent years. An increase from $2.39 billion in 2024 to $2.52 billion in 2025, marking a compound annual growth rate (CAGR) of 5.3% is anticipated. Factors such as an aging populace, rising prevalence of cancer, amplified spending on pharmaceutical research and development, elevated healthcare expenditures, and an increase in the volume of healthcare facilities, can be credited for this growth observed in the past.

The market for interventional oncology devices is set to experience significant expansion in the coming years, reaching a worth of $3.34 billion in 2029, at a compound annual growth rate (CAGR) of 7.3%. The rise during the forecast period is due to several factors such as an increase in elderly population, an upward trend in using minimally invasive surgeries (MIS), increased investment in research and development, enhanced healthcare spending, ambitious potential in developing nations, and the escalating prevalence of cancer and chronic illnesses. The forecast period is also expected to witness major trends such as concentration on the advancement of image-guided oncology devices, utilization of artificial intelligence for the creation of novel devices, development of innovative embolic devices for improved oncology procedures, emphasis on the integration of robotic technology and strategic partnerships with companies and research institutions to expedite the process of product development and innovation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Interventional Oncology Devices Market?

Top firms in the interventional oncology devices market are honing in on technologies like tissue volume, with the aim of boosting diagnostic precision and the efficiency of oncology treatments. The term tissue volume entails the measure of biological tissue gathered during a biopsy. A larger scope of tissue volumes can offer a more extensive range of samples, which in turn elevates diagnostic accuracy and the viability of treatment strategies. For example, Argon Medical, a medical device company based in the United States, unveiled the SuperCore Advantage semi-automatic biopsy in June 2023. The SuperCore Advantage is capable of securing up to 35% additional samples compared to its top competitors, thereby diminishing the necessity for numerous runs during biopsies. This capability is integral for accumulating sufficient tissue samples requisite for accurate diagnosis.

Which Key Market Segments Comprise the Interventional Oncology Devices Market and Drive Its Revenue Growth?

The interventional oncology devices market covered in this report is segmented –

1) By Product: Embolization Devices, Ablation Devices, Support Devices

2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization

3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:

1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices

3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Which Areas Are Leading Regions in the Interventional Oncology Devices Market Expansion Across the Globe?

North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Strategic Trends Steering theInterventional Oncology Devices Market Direction?

Significant firms are zeroing in on employing robotics technology in interventional oncology apparatus for improved efficiency. The system combines image-guided planning and direction with the attachment of various tools to the required body region with greater accuracy and effectiveness. As an illustration, Quantum Surgical’s Epione interventional oncology robotics platform received approval from the U.S. Food and Drug Administration in March 2022.

View the full report here:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

How Is the Interventional Oncology Devices Market Conceptually Defined?

Interventional oncology devices refer to medical tools and technologies used to diagnose and treat cancer through minimally invasive procedures. They are used to target tumors directly, delivering treatments like ablation or embolization while minimizing damage to surrounding healthy tissue.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3304

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model